Cinnabsin tablets №20×5

Name:
Cinnabsin tablets in pack No. 20×5
Description:
Tablets of white or almost white color, flat, with a bevelled edge, there may be inclusions of a darker color. Release form lozenges Dosage 100 pcs Dosage and administration Unless otherwise prescribed by a doctor, Cinnabsin is taken as follows: adults and children over 12 years of age with an acute course of the disease take 1 tablet every hour (but not more than 6 tablets per day) during the first two days . For subsequent treatment or in the chronic course of the disease, adults and children over 12 years of age take 1 tablet 1-3 times a day. When the severity of symptoms decreases, the frequency of administration should be reduced. Tablets should be taken half an hour before meals or half an hour after meals. Children from 6 to 12 years of age are prescribed half the adult dose. For this purpose, one tablet is dissolved in 6 teaspoons of water before use. A single dose corresponds to 3 teaspoons of the prepared solution, taken half an hour before or after meals. The rest of the solution is not subject to further use and must be destroyed. In the acute course of the disease, the solution (3 teaspoons) is taken every hour (but not more than 6 times a day) during the first two days. For subsequent treatment or in the chronic course of the disease, the solution (3 teaspoons) is taken 1-3 times a day. When the severity of symptoms decreases, the frequency of administration should be reduced. Cinnabsin should not be taken without medical advice for more than 4 weeks. The duration of the use of the drug is determined by the doctor. Use during pregnancy and lactation Due to the lack of sufficient data, taking the drug Cinnabsin during pregnancy or lactating women is possible only after consulting a doctor if the expected benefit to the mother outweighs the possible risk to the fetus or child who is breastfeeding. Precautions Homeopathic medicine. Before use, consult your doctor. If swelling of the face develops, fever, severe headache, new symptoms appear, and if your condition does not improve or worsens during the first 2 days of treatment, you should consult a doctor. The use of Cinnabsin is not recommended for: progressive systemic diseases (such as tuberculosis, sarcoidosis) systemic diseases of the leukocyte system (such as leukemia or leukemia) autoimmune diseases (such as systemic connective tissue diseases (collagenoses), multiple sclerosis) immunodeficiency (AIDS, HIV- infection) immunosuppression (for example, after organ or bone transplantation) After taking echinacea preparations, reports of the development of allergic reactions (skin rashes, itching, in rare cases, swelling of the face, shortness of breath, dizziness, lowering blood pressure) have been received. Echinacea may cause allergic reactions in patients with atopic diseases (eg, atopic dermatitis, asthma, hay fever). Therefore, patients with atopic diseases should consult a doctor before taking Cinnabsin. The use of drugs containing echinacea has been rarely associated with the occurrence of autoimmune diseases. Isolated cases have been reported when prolonged use of the drug (more than 8 weeks) led to a decrease in the number of leukocytes. Cinnabsin should not be administered to patients with galactose intolerance, lactase deficiency or glucose-galactose malabsorption. Wheat starch may contain traces of gluten, so caution should be exercised when treating patients with celiac disease. The effect of a homeopathic remedy may be reduced by smoking or other bad habits (such as drinking alcohol). Interaction with other drugs There is no information on interactions. In the case of simultaneous use of other drugs, you should consult your doctor. Contraindications Cinnabsin is contraindicated in patients with hypersensitivity to one of the active substances, to other plants of the Compositae family (Asteraceae / Compositae), or to other components that make up the drug. Cinnabsin is contraindicated in children under 6 years of age. The composition of the tablet contains: active substances: Cinnabaris trit. D3 25 mg, Hydrastis trit. D3 25 mg, Kalium bichromicum trit. D3 25 mg, Echinacea trit. D1 25 mg; excipients: lactose monohydrate, magnesium stearate, wheat starch. Overdose There is no information on cases of overdose. Side effectsAfter taking the drug Cinnabsin, hypersensitivity reactions, as well as nausea and vomiting, are possible. After taking echinacea preparations, reports of the development of allergic reactions (skin rashes, itching, swelling of the face, shortness of breath, dizziness, lowering blood pressure, bronchospastic reactions, anaphylactic shock, Stevens-Johnson syndrome) have been received. Echinacea may cause allergic reactions in patients with atopic diseases (eg, atopic dermatitis, asthma, hay fever). Wheat starch may cause hypersensitivity reactions. Due to the content of the mercury compound (Cinnabaris), increased salivation and the development of allergic reactions are possible. In these cases, you should stop using the drug and consult a doctor. When taking homeopathic medicines, a transient increase in existing symptoms of the disease (initial worsening) is possible; in this case, you should stop taking the drug and consult a doctor. Storage conditions Store in the original packaging at a temperature of 15 ° C to 25 ° C, out of the reach of children. Buy Cinnabsin tablets No. 20×5 Price for Cinnabsin tablets No. 20×5 Instructions for use for Cinnabsin tablets No. 20×5